Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 16,020 | 0 | 0 | 0 | 12 |
| Gross Profit | 16,020 | N/A | N/A | N/A | 12 |
| Operating Expenses | 11,510 | 12,587 | 12,310 | 14,236 | 6,881 |
| Operating Income | 4,510 | -12,587 | -12,310 | -14,236 | -6,869 |
| Interest Expense | 21 | 11 | 9 | 7 | 4 |
| Other Income | 1,171 | 174 | -1,379 | 279 | 23 |
| Pre-tax Income | 5,660 | -12,424 | -13,697 | -13,963 | -6,850 |
| Income Tax | 2,065 | 90 | -113 | -193 | 12 |
| Net Income Continuous | 3,595 | -12,514 | -13,584 | -13,771 | -6,862 |
| Net Income | $3,595 | $-12,514 | $-13,584 | $-13,771 | $-6,862 |
| EPS Basic Total Ops | 0.93 | -24.25 | -166.97 | -514.13 | -536.45 |
| EPS Basic Continuous Ops | 0.93 | -23.26 | -167.03 | -514.31 | -538.11 |
| EPS Diluted Total Ops | 0.87 | -24.25 | -166.97 | -514.13 | -536.45 |
| EPS Diluted Continuous Ops | 0.87 | -23.26 | -167.03 | -514.31 | -538.11 |
| EPS Diluted Before Non-Recurring Items | 0.87 | -24.21 | -166.97 | -637.26 | -637.26 |
| EBITDA(a) | $4,634 | $-12,535 | $-12,268 | $-10,153 | $-6,836 |